ondansetron has been researched along with Eye Hemorrhage in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Eye Hemorrhage: Intraocular hemorrhage from the vessels of various tissues of the eye.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Perry, JD | 1 |
1 other study available for ondansetron and Eye Hemorrhage
Article | Year |
---|---|
Letter to the editor regarding article, "A challenging problem that concerns the aesthetic surgeon".
Topics: Antiemetics; Blindness; Eye Hemorrhage; Humans; Ondansetron; Postoperative Nausea and Vomiting | 2009 |